China makes all-out efforts to ensure supply of key drugs against COVID-19
BEIJING -- China has made all-out efforts to ensure the production and supply of key drugs against COVID-19, an official said Wednesday.
The country's daily production capacity of Chloroquine Phosphate can meet the demand of 100,000 people, Cao Xuejun, an official with the Ministry of Industry and Information Technology, told a press conference.
Daily production capacity of another drug, Arbidol, can meet the demand of 50,000 people. The daily production capacity of Favipiravir can meet the demand of 15,500 people, said Cao.
The country has also stepped up the production of Traditional Chinese medicine (TCM) against the disease. The daily production capacities of two TCM drugs -- Lianhua Qingwen Capsule and Jinhua Qinggan have reached 2 million boxes and 26,000 boxes, respectively, according to Cao.
- New study reveals snow-ground thermal coupling on Qinghai-Tibet Plateau
- Mainland official highlights greater opportunities for Taiwan businesses on mainland
- Students in Xinjiang's prestigious ski destination to embrace 1st 'snow break'
- Macao SAR chief executive delivers policy address on reform, economic diversification
- Chinese vice-premier calls for enhanced economic, trade exchanges on Eurasian continent
- Xizang enhances weather forecasting, public warning capabilities
